REXO2 Inhibitors

The chemical group referred to as REXO2 Inhibitors encompasses a broad spectrum of compounds whose central theme revolves around the modulation of nucleic acid metabolism. These compounds have diverse origins and mechanisms, yet they converge upon pathways that either directly or indirectly influence the activity of ribonucleases such as REXO2.

Compounds like Hydroxyurea, 5-Azacytidine, Cytarabine, and Decitabine serve as exemplars, shedding light on the myriad ways by which nucleotide pools and synthesis can be modulated. Hydroxyurea, for instance, takes on the crucial enzyme ribonucleotide reductase, steering the tide of nucleotide availability and thereby affecting the role of REXO2. Nucleoside analogs, represented here by 5-Azacytidine, Cytarabine, and Decitabine, underscore another layer of complexity. Their incorporation into the nucleic acid chains can disrupt the natural progression of DNA and RNA synthesis. Compounds like α-Amanitin, DRB, and Leptomycin B elucidate another dimension of RNA metabolism, targeting RNA polymerase II or the very infrastructure of nucleic acid transport and export.